The Small Business Administration (SBA), in consultation with the Department of the Treasury, issued additional guidance regarding PPP Loan Forgiveness for funds advanced as part of section 1106 of the […]
Read More
Join Medical Marketing Whiz and David Sproule of Blue & Co., as they discuss Tips for Keeping & Increasing Cash Flow of Your Practice. You’re going to learn: What you […]
Read More
In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B […]
Read More
A new issue is affecting some inpatient hospital and Skilled Nursing Facility (SNF) claims when an interrupted stay is billed at the end of the month. The system incorrectly assigns […]
Read More
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory […]
Read More
Since the initiation of Annual Wellness Visits (AWVs) in 2011, many health systems have attempted to increase the volume of these preventative visits for their Medicare and Medicare Advantage patients. […]
Read More
Merck & Co. is communicating directly with covered entities asking for contract pharmacy claim data to be submitted to Merck via a secure web portal. Merck states the data will […]
Read More
This article was originally published on April 22nd and was most recently updated on July 8th. It is being updated as new information becomes available. On July 4th, President Trump […]
Read More
Have you recently received Medicare bad debt audit adjustments that you felt were unfair? If so, you are not alone. MACs (Medicare Administrative Contractors) have been tightening their auditing standards and practices surrounding […]
Read More
On June 18, 2020, the Office of Management and Budget (OMB) issued Memorandum M-20-26, Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the […]
Read More
On August 28, 2026, the U.S. District Court for the District of Columbia vacated CMS’s 2023 rule addressing the treatment of Medicare Advantage (Part C) inpatient days in the Medicare […]
By Stephen Stringer, CPA, Director at Blue & Co. If there is one thing most plastic processors can agree on, it’s that operating a plastic manufacturing business has become increasingly […]
By Becca Meredith, CPA, FHFMA, Senior Manager at Blue & Co. For Medicare cost reporting periods ending on or after January 1, 2026, many acute care hospitals will have to […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
